Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers

Genome Research

Volumn 21, Issue 4, 2011, Pages 555-565

  Sérandour, Aurélien A ^a,b,c   Avner, Stéphane ^a,b,c   Percevault, Frédéric ^a,b,c   Demay, Florence ^a,b,c   Bizot, Maud ^a,b,c   Lucchetti Miganeh, Céline ^a,b,c   Barloy Hubler, Frédérique ^a,b,c   Brown, Myles ^d   Lupien, Mathieu ^e   Métivier, Raphaël ^a,b,c   Salbert, Gilles ^a,b,c   Eeckhoute, Jérôme ^a,b,c,f  

^a UNIVERSITÉ DE RENNES 1   (France)

^b CNRS   (France)

^c UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

^f UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; HISTONE H3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOX A1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CHROMATIN STRUCTURE; CPG ISLAND; DNA FLANKING REGION; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHROMATIN; DNA METHYLATION; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; EPIGENOMICS; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HISTONES; HUMANS; MICE; MODELS, GENETIC; NEURONS;

MAMMALIA;

EID: 79953319002     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.111534.110     Document Type: Article

References (69)

1. Aiba K, Nedorezov T, Piao Y, Nishiyama A, Matoba R, Sharova LV, Sharov AA, Yamanaka S, Niwa H, Ko MS. 2009. Defining developmental potency and cell lineage trajectories by expression profiling of differentiating mouse embryonic stem cells. DNA Res 16: 73-80.
2. Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H. 2007. FOXA1 expression in breast cancer- correlation with luminal subtype A and survival. Clin Cancer Res 13: 4415-4421. (Pubitemid 47219708)
3. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. 2007.High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837. (Pubitemid 46802390)
4. Belikov S, Astrand C, Wrange O. 2009. FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptorregulated promoter. Mol Cell Biol 29: 5413-5425.
5. Brandt-Bohne U, Keene DR, White FA, Koch M. 2007. MEGF9: A novel transmembrane protein with a strong and developmentally regulated expression in the nervous system. Biochem J 401: 447-457. (Pubitemid 46166427)
6. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, et al. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33-43. (Pubitemid 40977938)
7. Cecchini KR, Raja Banerjee A, Kim TH. 2009. Towards a genome-wide reconstruction of cis-regulatory networks in the human genome. Semin Cell Dev Biol 20: 842-848.
8. Cedar H, Bergman Y. 2009. Linking DNA methylation and histone modification: Patterns and paradigms. Nat Rev Genet 10: 295-304.
9. Cheung E, Kraus WL. 2010. Genomic analyses of hormone signaling and gene regulation. Annu Rev Physiol 72: 191-218.
10. Cirillo LA, Lin FR, Cuesta I, Friedman D, Jarnik M, Zaret KS. 2002. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell 9: 279-289. (Pubitemid 34195554)
11. Crowe AJ, Sang L, Li KK, Lee KC, Spear BT, Barton MC. 1999. Hepatocyte nuclear factor 3 relieves chromatin-mediated repression of the alpha-fetoprotein gene. J Biol Chem 274: 25113-25120.
12. Culig Z, Hoffmann J, Erdel M, Eder IE, Hobisch A, Hittmair A, Bartsch G, Utermann G, Schneider MR, Parczyk K, et al. 1999. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer 81: 242-251. (Pubitemid 29423702)
13. Edwards JR, O'Donnell AH, Rollins RA, Peckham HE, Lee C, Milekic MH, Chanrion B, Fu Y, Su T, Hibshoosh H, et al. 2010. Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns. Genome Res 20: 972-980.
14. Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M. 2006. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev 20: 2513-2526. (Pubitemid 44396837)
15. Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M. 2007. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res 67: 6477-6483. (Pubitemid 47037533)
16. Eeckhoute J, Lupien M, Meyer CA, Verzi MP, Shivdasani RA, Liu XS, Brown M. 2009a. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res 19: 372-380.
17. Eeckhoute J, Metivier R, Salbert G. 2009b. Defining specificity of transcription factor regulatory activities. J Cell Sci 122: 4027-4034.
18. ENCODE Project Consortium, Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, et al. 2007. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816. (Pubitemid 46920138)
19. Farnham PJ. 2009. Insights from genomic profiling of transcription factors. Nat Rev Genet 10: 605-616.
20. Friedman JR, Kaestner KH. 2006. The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci 63: 2317-2328. (Pubitemid 44653042)
21. Gao N, Zhang J, Rao MA, Case TC, Mirosevich J, Wang Y, Jin R, Gupta A, Rennie PS, Matusik RJ. 2003. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol Endocrinol 17: 1484-1507. (Pubitemid 36930465)
22. Hajkova P, Ancelin K, Waldmann T, Lacoste N, Lange UC, Cesari F, Lee C, Almouzni G, Schneider R, Surani MA. 2008. Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 452: 877-881. (Pubitemid 351550855)
23. He HH, Meyer CA, Shin H, Bailey ST, Wei G, Wang Q, Zhang Y, Xu K, Ni M, Lupien M, et al. 2010. Nucleosome dynamics define transcriptional enhancers. Nat Genet 42: 343-347.
24. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318. (Pubitemid 46328487)
25. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, et al. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459: 108-112.
26. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576-589.
27. Hoffman BG, Robertson G, Zavaglia B, Beach M, Cullum R, Lee S, Soukhatcheva G, Li L, Wederell ED, Thiessen N, et al. 2010. Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver. Genome Res 20: 1037-1051.
28. Hua S, Kittler R, White KP. 2009. Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 137: 1259-1271.
29. Jacob A, Budhiraja S, Reichel RR. 1997. Differential induction of HNF-3 transcription factors during neuronal differentiation. Exp Cell Res 234: 277-284. (Pubitemid 27335168)
30. Johnson WE, Li W, Meyer CA, Gottardo R, Carroll JS, Brown M, Liu XS. 2006. Model-based analysis of tiling-arrays for ChIP-chip. Proc Natl Acad Sci 103: 12457-12462. (Pubitemid 44267281)
31. Jones PA, Liang G. 2009. Rethinking how DNA methylation patterns are maintained. Nat Rev Genet 10: 805-811.
32. Jones-Villeneuve EM, Rudnicki MA, Harris JF, McBurney MW. 1983. Retinoic acid-induced neural differentiation of embryonal carcinoma cells. Mol Cell Biol 3: 2271-2279. (Pubitemid 14224710)
33. Klose RJ, Bird AP. 2006. Genomic DNA methylation: The mark and its mediators. Trends Biochem Sci 31: 89-97. (Pubitemid 43221841)
34. Klug M, Rehli M. 2006. Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics 1: 127-130.
35. Lacroix M, Leclercq G. 2004. About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer. Mol Cell Endocrinol 219: 1-7. (Pubitemid 38659520)
36. Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguere V. 2005. Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci 102: 11651-11656.
37. Lefterova MI, Steger DJ, Zhuo D, Qatanani M, Mullican SE, Tuteja G, Manduchi E, Grant GR, Lazar MA. 2010. Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages. Mol Cell Biol 30: 2078-2089.
38. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, et al. 2009. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315-322.
39. Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, Brown M. 2008. FoxA1 translates epigenetic signatures into enhancer driven lineage-specific transcription. Cell 132: 958-970. (Pubitemid 351391952)
40. Malik S, Jiang S, Garee JP, Verdin E, Lee AV, O'Malley BW, Zhang M, Belaguli NS, Oesterreich S. 2010. Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM. Mol Cell Biol 30: 399-412.
41. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763. (Pubitemid 38030303)
42. Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, Carmouche RP, Ibberson D, Barath P, Demay F, Reid G, et al. 2008. Cyclical DNA methylation of a transcriptionally active promoter. Nature 452: 45-50. (Pubitemid 351355084)
43. Mirosevich J, Gao N, Gupta A, Shappell SB, Jove R, Matusik RJ. 2006. Expression and role of Foxa proteins in prostate cancer. Prostate 66: 1013-1028. (Pubitemid 43939204)
44. Motallebipour M, Ameur A, Reddy Bysani MS, Patra K, Wallerman O, Mangion J, Barker MA, McKernan KJ, Komorowski J, Wadelius C. 2009. Differential binding and co-binding pattern of FOXA1 and FOXA3 and their relation to H3K4me3 in HepG2 cells revealed by ChIP-seq. Genome Biol 10: R129. doi: 10.1186/gb-2009-10-11- r129.
45. Nakshatri H, Badve S. 2009. FOXA1 in breast cancer. Expert Rev Mol Med 11: e8. doi: 10.1017/S1462399409001008.
46. Nucera C, Eeckhoute J, Finn S, Carroll JS, Ligon AH, Priolo C, Fadda G, Toner M, Sheils O, Attard M, et al. 2009. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin Cancer Res 15: 3680-3689.
47. O'Geen H, Nicolet CM, Blahnik K, Green R, Farnham PJ. 2006. Comparison of sample preparation methods for ChIP-chip assays. Biotechniques 41: 577-580. (Pubitemid 46534868)
48. Okitsu CY, Hsieh CL. 2007. DNA methylation dictates histone H3K4 methylation. Mol Cell Biol 27: 2746-2757. (Pubitemid 46581362)
49. Ooi SK, Qiu C, Bernstein E, Li K, Jia D, Yang Z, Erdjument-Bromage H, Tempst P, Lin SP, Allis CD, et al. 2007. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448: 714-717. (Pubitemid 47236857)
50. Phillips JE, Corces VG. 2009. CTCF: Master weaver of the genome. Cell 137: 1194-1211.
51. Ruike Y, Imanaka Y, Sato F, Shimizu K, Tsujimoto G. 2010. Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics 11: 137. doi: 10.1186/1471-2164-11-137.
52. Schmidl C, Klug M, Boeld TJ, Andreesen R, Hoffmann P, Edinger M, Rehli M. 2009. Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res 19: 1165-1174.
53. Sekiya T, Muthurajan UM, Luger K, Tulin AV, Zaret KS. 2009. Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA. Genes Dev 23: 804-809.
54. Shin H, Liu T, Manrai AK, Liu XS. 2009. CEAS: cis-regulatory element annotation system. Bioinformatics 25: 2605-2606.
55. Steger DJ, Grant GR, Schupp M, Tomaru T, Lefterova MI, Schug J, Manduchi E, Stoeckert CJ Jr, Lazar MA. 2010. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev 24: 1035-1044.
56. Suganuma T, Workman JL. 2008. Crosstalk among histone modifications. Cell 135: 604-607.
57. Tan Y, Xie Z, Ding M, Wang Z, Yu Q, Meng L, Zhu H, Huang X, Yu L, Meng X, et al. 2010. Increased levels of FoxA1 transcription factor in pluripotent P19 embryonal carcinoma cells stimulate neural differentiation. Stem Cells Dev 19: 1365-1374.
58. Thomson JP, Skene PJ, Selfridge J, Clouaire T, Guy J, Webb S, Kerr AR, Deaton A, Andrews R, James KD, et al. 2010. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 464: 1082-1086.
59. Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S. 2008. Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis. J Clin Pathol 61: 327-332. (Pubitemid 351354239)
60. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Chen F, et al. 2009a. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457: 854-858.
61. Visel A, Rubin EM, Pennacchio LA. 2009b. Genomic views of distant-acting enhancers. Nature 461: 199-205.
62. Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, et al. 2009. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138: 245-256.
63. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. 2005. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37: 853-862. (Pubitemid 41077111)
64. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M, Schubeler D. 2007. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39: 457-466. (Pubitemid 46514772)
65. Xu J, Watts JA, Pope SD, Gadue P, Kamps M, Plath K, Zaret KS, Smale ST. 2009. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev 23: 2824-2838.
66. Yao J, Liu Y, Husain J, Lo R, Palaparti A, Henderson J, Stifani S. 1998. Combinatorial expression patterns of individual TLE proteins during cell determination and differentiation suggest non-redundant functions for mammalian homologs of Drosophila Groucho. Dev Growth Differ 40: 133-146. (Pubitemid 28180617)
67. Zaret K. 1999. Developmental competence of the gut endoderm: Genetic potentiation by GATA and HNF3/fork head proteins. Dev Biol 209: 1-10. (Pubitemid 29194308)
68. Zemach A, McDaniel IE, Silva P, Zilberman D. 2010. Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science 328: 916-919.
69. Zilberman D, Coleman-Derr D, Ballinger T, Henikoff S. 2008. Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. Nature 456: 125-129.